As of 2025-09-18, the Relative Valuation of Xphyto Therapeutics Corp (XPHY.CN) is (1.11) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on Relative Valuation is -324.7%.
The range of the Relative Valuation is (0.91) - (1.30) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 10.6x | 8.8x |
| Forward P/E multiples | 7.4x - 11.2x | 9.3x |
| Fair Price | (0.91) - (1.30) | (1.11) |
| Upside | -284.7% - -362.2% | -324.7% |
| Date | P/E |